Le Registre des lobbyistes
Eli Lilly Canada Inc.
Objets | Détails | Catégories |
---|---|---|
Relations fédérales-provinciales, Santé, Recherche et développement
|
Bill C-64, An Act respecting pharmacare (Pharmacare Act)
|
Proposition législative, Projet de loi ou résolution
|
Santé, Recherche et développement, Sciences et technologies
|
Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food & Drug Act.
|
Proposition législative, Projet de loi ou résolution
|
Commerce international
|
Free trade treaty agreement as it relates to the Canada US Free Trade Agreement (CUSMA) and free trade negotiations as it relates to Columbia, India, and the European Union.
|
Politique ou Programme
|
Santé, Propriété intellectuelle
|
Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly's business.
|
Règlement
|
Santé, Propriété intellectuelle, Sciences et technologies
|
Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention.
|
Proposition législative, Projet de loi ou résolution
|
Santé, Industrie, Propriété intellectuelle
|
Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry.
|
Règlement
|
Industrie, Propriété intellectuelle, Impôts et finances
|
Patented Medicines Prices Review Board (PMPRB) proposed regulations, in regards to pharmaceutical pricing policy.
|
Politique ou Programme
|
Santé, Sciences et technologies
|
The government's Science and Technology Strategy potential policies & programs pertaining to the biopharmaceutical industry.
|
Politique ou Programme
|